文献速递免疫规划传染病防控与疫情报告

展示CA16保守表位的嵌合EV71病毒样颗粒可诱导强免疫应答并保护小鼠

Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
PubMed 文献 · Vaccine · 2021-06-09

本研究在Sf9细胞中制备EV71病毒样颗粒(VLP)及其展示单个或四个CA16保守中和表位的嵌合体。小鼠实验中,嵌合VLP诱导的EV71特异性IgG和中和抗体与灭活EV71相当,且CA16特异性IgG和中和抗体显著升高,交叉保护增强;新生鼠获得完全抗EV71和部分抗CA16致死攻击的保护。

要点

  • 嵌合VLP ChiEV71(4E)-VLP展示CA16四个保守中和表位。
  • 嵌合VLP诱导的EV71免疫应答与灭活疫苗相当。
  • 嵌合VLP增强CA16交叉保护,新生鼠部分抗CA16致死攻击。

核心结论

  • 展示CA16保守表位的EV71嵌合VLP可诱导EV71和CA16双重免疫应答及交叉保护。

研究设计与样本

  • 利用重组杆状病毒Bac-P1-3CD在Sf9细胞中共表达EV71 P1和3CD蛋白制备VLP。
  • 构建展示单个CA16 PEP71表位或四个CA16保守中和表位的EV71嵌合VLP。
  • 在小鼠中比较VLP、嵌合VLP与灭活EV71/CA16的免疫原性和保护效果。

主要发现

  • EV71-VLP及其嵌合体诱导的EV71特异性IgG和中和抗体滴度与灭活EV71相似。
  • ChiEV71(1E)-VLP或ChiEV71(4E)-VLP免疫显著增加CA16特异性IgG和中和抗体产生。
  • 嵌合VLP较EV71-VLP改善对CA16感染的交叉保护。
  • VLP诱导强细胞免疫应答并显著降低脾细胞Th2型细胞因子(IL-4和IL-10)分泌。
  • 嵌合VLP免疫母鼠的新生鼠或被动转移免疫血清的新生鼠完全抵抗致死EV71攻击、部分抵抗致死CA16感染。

关键数值与推荐

  • ChiEV71(4E)-VLP在VP1、VP2、VP3和VP4中分别展示CA16表位PEP71、aa136-150、aa176-190和aa48-62。

临床怎么用

  • 提示双价或多价VLP疫苗策略可用于预防EV71及相关肠道病毒感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hand-foot-and-mouth disease (HFMD) is an infectious disease of infants and young children frequently caused by the enterovirus A species, mainly enterovirus 71 (EV71) and coxsackievirus A16 (CA16). In this study, we prepared the EV71 virus-like particle (EV71-VLP) and its chimeras using recombinant baculovirus (Bac-P1-3CD) co-expressing EV71 P1 (under polyhedrin promoter) and 3CD (under CMV-IE promoter) proteins in Sf9 cells. EV71-VLP chimera ChiEV71(1E)-VLP or ChiEV71(4E)-VLP displayed single CA16 PEP71 epitope in VP1 or four conserved CA16 neutralizing epitopes (PEP71 in VP1, aa136-150 in VP2, aa176-190 in VP3 and aa48-62 in VP4) by substitution of the corresponding regions of EV71 structure proteins, respectively. In mice, EV71-VLP and its chimeras elicited similar EV71-specific IgG and neutralizing antibody (NAb) titers compared to inactivated EV71. Expectedly, vaccination of ChiEV71(1E)-VLP or ChiEV71(4E)-VLP resulted in significantly increased CA16-specific IgG and NAb production and improved cross-protection against CA16 infection compared to EV71-VLP. Interestingly, the VLPs induced potent cellular immune responses and significantly decreased Th2 type (IL-4 and IL-10) cytokines secretion in the splenocytes of immunized mice compared to inactivated EV71 or inactivated CA16. Neonatal mice born to dams immunized with the chimeric VLPs or neonatal mice passively transferred with sera of immunized mice were completely protected from lethal EV71 challenge and partially protected from lethal CA16 infection. Our study provides a novel bivalent or multivalent vaccine strategy to prevent EV71 and related-enterovirus infections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Luo J, Huo C, Qin H, et al. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection. Vaccine. 2021. PMID: 34116877. doi:10.1016/j.vaccine.2021.05.093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。